BUSINESS Alembic Pharmaceuticals notifies shareholders of unclaimed dividends transfer to IEPF May 4, 2026
BUSINESS Alembic Pharmaceuticals receives USFDA approval for Fingolimod Capsules with market size of US$ 145 million Apr 25, 2026
Alembic Pharmaceuticals receives USFDA approval for Dapagliflozin tablets with US$ 10.487 billion market size Apr 7, 2026
Alembic Pharmaceuticals gets USFDA final approval for Carbidopa, Levodopa and Entacapone tablets Feb 6, 2026
Alembic Pharmaceuticals secures USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3% Dec 11, 2025
Alembic Pharmaceuticals gets USFDA final approval for Amlodipine and Atorvastatin Tablets May 23, 2025
Alembic Pharmaceuticals shares drop 2% as Q4 net profit falls 11.9% YoY to Rs 156.89 crore May 6, 2025